We thank Kim Barrymore for editing the manuscript. This project was supported by the Japan Science and Technology Agency within the framework of the Science and Technology Research Partnership for Sustainable Development and the Japan Initiative for Global Research Network on Infectious Diseases. Katendi Changula was also sponsored by the Southern African Center for Infectious Diseases Surveillance with Wellcome Trust Grant WT087546MA. The authors declare no conflict of interest. “
“It is known that NB-UVB therapy can suppress a broad range of immune cells, but the additional effect of bathing in geothermal
seawater still remains unclear. To study the influence of treatment on the expression of circulating immune cells contributing to the pathogenesis of psoriasis, six patients with psoriasis were treated with bathing BTK assay in geothermal seawater two times daily combined with NB-UVB five times/week for 2 weeks and six patients were treated with NB-UVB therapy three times/week for 8 weeks. Disease severity (Psoriasis Area and Severity Index, PASI), chemokines, inflammatory cytokines,
T cells and Toll-like receptors in the blood and skin samples were evaluated on enrolment (W0) and at Rucaparib datasheet 1 (W1), 3 (W3) and 8 (W8) weeks. Compared with healthy controls, psoriasis patients with active disease had significantly higher proportion of peripheral
CLA+ T cells expressing CCR10 and CD103 and T cells with both Th1/Tc1 (CD4+/CD8+ IFN-γ+ or TNF-α+ cells) and Th17/Tc17 (CD4+CD45R0+IL-23R+, CD4+/CD8+ IL-17A+ or IL-22+ cells) phenotypes. Both treatments gave a significant clinical effect; however, bathing in geothermal seawater combined with NB-UVB therapy was more effective than NB-UVB therapy alone. This clinical improvement was reflected by a reduction in circulating CLA+ peripheral blood T cells and by a decreased Th1/Th17 and Tc1/Tc17 inflammatory response. These Tideglusib findings suggest that the inflammatory response in psoriasis is predominantly driven by both CD4+ and CD8+ skin-homing tissue retaining T cells of the Th17/Tc17 lineages. Bathing in geothermal seawater from the Blue Lagoon (BL) in Iceland has been reported to have a beneficial effect on psoriasis [1, 2]. Additional treatment with narrow-band ultraviolet (NB-UVB) phototherapy further increases the efficacy of the treatment [3-5]. The BL contains geothermal seawater originating from underground reservoirs filled with a mixture of fresh water and seawater. Sampling from the lagoon shows that no pathogenic bacteria thrive in this ecosystem [6]. The fluid in the lagoon has a high level of silica but is moderate in temperature (37 °C) and salinity (2.7%) [7].